A completely new type of digital dermatoscope has been developed in order to take a significant step forward in technology for skin cancer imaging. By means of this study a better insight can be gained of the current performance and workflow in clinical dermatoscopy. This knowledge will be used to further improve the developed technology.

Inclusion Criteria:

• Participant is willing and able to give informed consent for participation in the study.
• Male or Female, aged 18 years or above.
• Male or Female, aged less than 18 years, with informed consent of their legally authorized representative.
• Patient presenting with any visible skin lesion for dermatologist review on a body site amenable to optimal photographic imaging.
• Able and willing to comply with all study requirements.
• Patient with a skin lesion that is clinically diagnosed by a dermatologist as benign, malignant or a suspicious skin lesion requiring excisional biopsy for histological diagnosis.

Exclusion Criteria:

• Patients aged under 18 years old where the legally authorized representative is unable or unwilling to provide their informed consent.
• Patients unable to provide informed consent.
• Skin lesions in an anatomical site which is not suitable for photography including hair-obscured site, subungual lesion or inaccessible mucosal site.
• Lesion is at a site where previous surgery was undertaken.

Patients will be considered for enrollment in the study when they have a lesion that is accessible to the new digital dermatoscope and are able to give informed consent (guardian in case of patients under 18 years).